Search

Search Results

• 

  Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study

  Carlos A. Jiménez-Ruiz, Marcos Garcia Rueda, Manuel A. Martinez Muñiz, Jacobo Sellarés, Maria A. Jiménez-Fuentes, Lourdes Lázaro Asegurado, Esther Rodríguez Gonzalez, Concepción Rodriguez Garcia, Oriol Armengol, Emilia Abad, Teresa Peña, Adolfo Domenech del Rio, Juan A. Riesco Miranda

  2017-12-19

  Published: December 19, 2017

  1641

  PDF: 890

  Supplementary: 216
• 

  A study on the prevalence of depression and the severity of depression in patients of chronic obstructive pulmonary disease in a semi-urban Indian population

  Abhishekl Agarwal, Sakshi Batra, Rajendra Prasad, Anand Verma, Abdul Q. Jilani, Surya Kant

  2018-03-19

  Published: March 19, 2018

  1775

  PDF: 853
• 

  Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD

  Claudio F. Donner, Sandro Amaducci, Elena Bacci, Sandra Baldacci, Maria L. Bartoli, Gianfranco M. Beghi, Alida Benfante, Sara Brighindi, Lucio Casali, Daniela Castiglia, Mario Cazzola, Alessandro Celi, Silvana Cianchetti, Giorgio Colombo, Claudia Crimi, Federico L. Dente, Giuseppe Di Maria, Annalisa Di Maria, Manuela Latorre, Federico Lavorini, Sara Maio, Claudia Mannini, Riccardo Messina, Pier Luigi Paggiaro, Patrizia Pignatti, David Price, Nicola Scichilone, Marzia Simoni, Antonio Spanevello, Martina Stagno d’Alcontres, Shawna Tan, Roberto Torchio, Giovanni Viegi, Dina Visca, Emiel F.M. Wouters, Shaylynn Yu Hui Xin

  2018-02-02

  Published: February 2, 2018

  3096

  PDF: 1339

• Sharing knowledge is the key to success in a patient-physician relationship: how to produce a patient information leaflet on COPD

  D. Scala, S. Cozzolino, G. D’Amato, G. Cocco, A. Sena, P. Martucci, E. Ferraro, A.A. Mancini

  2016-01-26

  Published: January 26, 2016

  986

  PDF: 581
• 

  Health-related quality of life, lung function and dyspnea rating in COPD patients

  M. Justine, F. Tahirah, V. Mohan

  2013-12-30

  Published: December 30, 2013

  1536

  PDF: 931

• GOLD severity stratification and risk of hospitalisation for COPD exacerbations

  M. Lusuardi, C. Lucioni, F. De Benedetto, S. Mazzi, C.M. Sanguinetti, C.F. Donner

  2016-01-26

  Published: January 26, 2016

  2060

  PDF: 1057

• Hospitalisation for COPD in Puglia: the role of hospital discharge database to estimate prevalence and incidence

  P. Trerotoli, N. Bartolomeo, A.M. Moretti

  2016-01-26

  Published: January 26, 2016

  753

  PDF: 438

• Phenomenology of COPD: interpreting phenotypes with the ECLIPSE study

  Alberto Papi, Maria Sandra Magnoni, Carmelo Caio Muzzio, Gianmarco Benso, Andrea Rizzi

  2016-10-14

  Published: October 14, 2016

  2712

  PDF: 1634

• Degree of control of physiciandiagnosed asthma and COPD in Italy

  G. Caramori, G. Bettoncelli, M. Carone, R. Tosatto, P. Di Blasi, A. Pieretto, G. Invernizzi, B. Franco Novelletto, A. Ciaccia, I.M. Adcock, A. Papi

  2016-02-03

  Published: February 3, 2016

  888

  PDF: 522

• The role of noninvasive methods in assessing airway inflammation and structural changes in asthma and COPD

  K. Ahmad Dar, M. Shahid, A. Mubeen, R. Bhargava, Z. Ahmad, I. Ahmad, N. Islam

  2015-12-03

  Published: December 3, 2015

  1380

  PDF: 702

• Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy

  G. Caramori, G. Bettoncelli, R. Tosatto, F. Arpinelli, G. Visonà, G. Invernizzi, B.F. Novelletto, A. Papi, I.M. Adcock, A. Ciaccia

  2005-03-30

  Published: March 30, 2005

  1462

  PDF: 888

• The use of roflumilast in COPD: a review

  Andrea Zanini, Francesca Cherubino, Patrizia Pignatti

  2015-08-19

  Published: August 19, 2015

  851

  PDF: 626

• COPD and tobacco smoke

  M. Bartal

  2005-12-30

  Published: December 30, 2005

  4316

  PDF: 2145

• Long-Term Oxygen Therapy in COPD: evidences and open questions of current indications

  A. Corrado, T. Renda, S. Bertini

  2016-01-19

  Published: January 19, 2016

  7300

  PDF: 2804

• Association of ET-1 gene polymorphisms with COPD phenotypes in a Caucasian population

  A. Kaparianos, F. Sampsonas, D. Lykouras, G. Efremidis, P. Drakatos, K. Karkoulias, C. Gogos, K. Spiropoulos

  2015-12-10

  Published: December 10, 2015

  1155

  PDF: 541

• Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects

  M. Malerba, B. Ragnoli, M. Corradi

  2016-01-26

  Published: January 26, 2016

  801

  PDF: 569
• 

  Depression, anxiety and chronic pain in patients with chronic obstructive pulmonary disease: the influence of breath

  Bruno Bordoni, Fabiola Marelli, Bruno Morabito, Beatrice Sacconi

  2017-05-25

  Published: May 25, 2017

  8460

  PDF: 6775

• Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation - The Italian SOS (Stratification Observational Study)

  M. Lusuardi, F. Blasi, C. Terzano, C. Cricelli, N. Crispino, L. Comarella, F. De Benedetto, C.M. Sanguinetti, L. Allegra, C.F. Donner

  2016-01-21

  Published: January 21, 2016

  995

  PDF: 554

• Prevalence and impact of anxiety and depression in patients with chronic obstructive pulmonary disease: a comparative analysis of post-tuberculosis and non-tuberculosis chronic obstructive pulmonary disease cases

  Eshutosh Chandra, Shipra Anand, Amitesh Gupta, Roopam Jha, Irshad Ahmad

  2025-03-03

  Published: March 3, 2025

  470

  PDF_EARLY VIEW: 132

• Different outcomes of pulmonary rehabilitation in patients with COPD with or without exacerbations

  G.G. Riario-Sforza, C. Incorvaia, F. Paterniti, N. Dugnani, M. Fumagalli

  2005-09-30

  Published: September 30, 2005

  1002

  PDF: 515

• Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease

  P. Santus, F. Casanova, M.L. Biondi, F. Blasi, F. Di Marco, S. Centanni

  2016-01-25

  Published: January 25, 2016

  883

  PDF: 438

• Nutritional status and airflow obstruction: two independent contributors to CO diffusing capacity impairment in COPD

  S. Baldi, G.D. Pinna, P. Crotti, S. Montemartini, E. Dacosto, F. Fanfulla, C. Fracchia, C. Bruschi

  2005-03-30

  Published: March 30, 2005

  591

  PDF: 444

• Association of severity of COPD with IgE and interleukin-1beta

  B. Singh, S. Arora, V. Khanna

  2016-01-19

  Published: January 19, 2016

  1594

  PDF: 954

• Roflumilast is safe and effective in improving symptoms and lung function in severe COPD

  Matteo Bonini, Paolo Palange

  2015-08-19

  Published: August 19, 2015

  841

  PDF: 612

• Smoking cessation treatment for COPD smokers: the role of counselling

  C.A. Jiménez-Ruiz, K.O. Fagerström

  2015-11-26

  Published: November 26, 2015

  2677

  PDF: 1293
• 

  Integrating the care of the complex COPD patient

  Claudio F. Donner, Laura Carrozzi, Sara Maio, Sandra Baldacci, Francesco Pistelli, Giovanni Viegi, Andrea Purro, Roberto Torchio, Enrico Clini, Sandro Amaducci, Richard L. ZuWallack, Roger Goldstein, Michael Morgan, Jean Bourbeau, Guido Vagheggini, Emiel F.M. Wouters

  2017-05-18

  Published: May 18, 2017

  2253

  PDF: 945

• Smoking cessation treatment for COPD smokers: the role of pharmacological interventions

  C.A. Jiménez-Ruiz, K.O. Fagerström

  2015-11-26

  Published: November 26, 2015

  2631

  PDF: 1466

• Rehabilitation of COPD patients: which training modality

  E. Clini, S. Costi, M. Romagnoli, F. Florini

  2004-09-30

  Published: September 30, 2004

  1077

  PDF: 609

• Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design

  Raffaele Griffo, Antonio Spanevello, Pier Luigi Temporelli, Pompilio Faggiano, Mauro Carone, Giovanna Magni, Nicolino Ambrosino, Luigi Tavazzi

  2015-08-19

  Published: August 19, 2015

  1607

  PDF: 1080

• Contribution of bronchial biopsies in the evaluation of pathogenesis and progression of COPD

  F. Magno, A. Di Stefano

  2016-02-03

  Published: February 3, 2016

  685

  PDF: 338

• Randomized trial of paroxetine in end-stage COPD

  Y. Lacasse, L. Beaudoin, L. Rousseau, F. Maltais

  2004-09-30

  Published: September 30, 2004

  1858

  PDF: 714
• 

  Identification of subclinical cognitive impairment in chronic obstructive pulmonary disease using auditory P300 event related potential

  Soundariya Krishnamurthy, Yuvarajan Sivagnaname, Gokul Chandu Gumallapu

  2019-05-24

  Published: May 24, 2019

  1424

  PDF: 924
• 

  Assessment of prevalence and characteristics of asthma-COPD overlap among patients with chronic airflow obstruction

  Kapil Kumar, Prem Parkash Gupta, Arvind Kumar Verma, Rohtas Yadav

  2022-09-02

  Published: September 2, 2022

  1542

  PDF: 626

• Heart and Lungs in COPD. Close friends in real life - separate in daily medical practice?

  M. Lusuardi, G. Garuti, M. Massobrio, L. Spagnolatti, S. Bendinelli

  2016-01-26

  Published: January 26, 2016

  1726

  PDF: 903

• Essential amino acid supplementation in patients with severe COPD: a step towards home rehabilitation

  R.W. Dal Negro, A. Testa, R. Aquilani, S. Tognella, E. Pasini, A. Barbieri, F. Boschi

  2015-12-03

  Published: December 3, 2015

  3647

  PDF: 1824

• Comprehensive exercise training improves ventilatory muscle function and reduces dyspnea perception in patients with COPD

  F. Cortopassi, A.A.M. Castro, E.F. Porto, M. Colucci, G. Fonseca, L. Torre-Bouscoulet, V. Iamonti, J.R. Jardim

  2016-01-21

  Published: January 21, 2016

  1962

  PDF: 1026
• 

  Role of interleukin-6 and insulin resistance as screening markers for metabolic syndrome in patients of chronic obstructive pulmonary disease. A hospital-based cross-sectional study

  Manu Dogra, Surabhi Jaggi, Deepak Aggarwal, Seema Gupta, Varinder Saini, Jasbinder Kaur

  2021-12-28

  Published: December 28, 2021

  2676

  PDF: 616

• Water and sodium imbalance in COPD patients

  G. Valli, A. Fedeli, R. Antonucci, P. Paoletti, P. Palange

  2004-06-30

  Published: June 30, 2004

  3956

  PDF: 1557

• Physiological effects of intravenous fructose 1.6-diphosphate on diaphragmatic function in malnourished patients with COPD

  S. Nava, L.M. Fuccella, B. Viglianti

  2004-12-30

  Published: December 30, 2004

  680

  PDF: 510

• Lung and respiratory muscle function at discharge from a respiratory intensive care unit

  M. Vitacca, L. Bianchi, L. Barbano, N. Ambrosino

  2005-09-30

  Published: September 30, 2005

  670

  PDF: 435

• Monocyte-related hematological indices in acute exacerbations of chronic obstructive pulmonary disease – a new biomarker?

  Višnja Dukić, Davorka Muršić, Sanja Popović Grle, Marko Jakopović, Alen Ružić, Andrea Vukić Dugac

  2023-09-25

  Published: September 25, 2023

  888

  PDF: 59

• Prevalence and risk factors for chronic pulmonary aspergillosis in chronic obstructive pulmonary disease patients with acute exacerbations

  Jayabharathi Palanivel, Madhusmita Mohanty Mohapatra, Manju Rajaram, Debasis Gochhait, Sunitha Vellathussery Chakkalakkoombil, Rakesh Singh

  2024-03-21

  Published: March 21, 2024

  965

  PDF_EARLY VIEW: 390

• Inspiratory muscle workload due to dynamic intrinsic PEEP in stable COPD patients: effects of two different settings of non-invasive pressure-support ventilation

  M. Vitacca, B. Lanini, S. Nava, L. Barbano, R. Porta, E. Clini, N. Ambrosino

  2004-06-30

  Published: June 30, 2004

  787

  PDF: 659

• Induced sputum in the management of COPD: clinical implications

  A. Zanini, S. Della Patrona, A.L. Facchini, A. Spanevello

  2015-12-03

  Published: December 3, 2015

  1035

  PDF: 573

• Features of hospitalisations for acute exacerbation of COPD resulting in death

  T. Kinnunen, O. Säynäjäkangas, T. Keistinen

  2016-02-03

  Published: February 3, 2016

  741

  PDF: 491

• Roflumilast is effective in reducing COPD related exacerbations and improving CAT score

  Biagio Polla

  2015-08-19

  Published: August 19, 2015

  820

  PDF: 614

• Addressing inhaler technique challenges in cognitively impaired chronic obstructive pulmonary disease patients: the impact of customized training programs

  Vaishnavi V Gaonkar, Vinay V Shanbhag, Shreya S Kajave, Mahek R Mattikop, Mandati Santhosh Reddy

  2025-01-08

  Published: January 8, 2025

  484

  PDF_EARLY VIEW: 126

• Assessment of health status and its correlation with lung function in patients with chronic obstructive pulmonary disease: a study from a tertiary care center in north India

  Ankur Gupta, Kranti Garg, Vishal Chopra, Surinder Pal Singh

  2023-06-07

  Published: June 7, 2023

  1075

  PDF: 387

  SUPPLEMENTARY MATERIAL: 32

• Chronic obstructive pulmonary disease and heart failure in real life: the tip of the iceberg in the sea of comorbidities. A prospective observational study

  Ombretta Para, Marco Vanetti, Chiara Dibonaventura, Davide Salerno, Lorenzo Caruso, Christian Carleo, Asim Raza, Carlo Nozzoli, Antonio Spanevello

  2025-02-04

  Published: February 4, 2025

  456

  PDF_EARLY VIEW: 152
• 

  Prevalence, risk factors and effects of restless legs syndrome in COPD patients

  Shweta Anand, Anshul Jain, Dipti Gothi, Sameer Vaidya, Rambabu Sah

  2022-07-04

  Published: July 4, 2022

  1376

  PDF: 581